Alpha 2.0
Login Register
» Articles » PMID: 17895770

Is Phosphatemia the Best Tool to Monitor Renal Tenofovir Toxicity?

Overview
Journal J Acquir Immune Defic Syndr
Specialty Infectious Diseases
Date 2007 Sep 27
PMID 17895770
Citations 7
Authors
Marie Essig
Xavier Duval
Firas Al Kaied
Laura Iordache
Anne Gervais
Pascale Longuet
Francoise Blanchet
Gilles Peytavin
Catherine Leport
Affiliations
Soon will be listed here.
Citing Articles

Clinical consequence of hypophosphatemia during antiviral therapy for chronic hepatitis B.

Park M, Jeon H, Park K, Jeon J, Park M, Chi S Kidney Res Clin Pract. 2025; 44(1):123-131.

PMID: 39849861 PMC: 11877809. DOI: 10.23876/j.krcp.22.197.

Non-Inferior Efficacy of Tenofovir Disoproxil to Tenofovir Disoproxil Fumarate in Virologically Suppressed Chronic Hepatitis B Patients.

Yim H, Kim J, Cho Y, Kweon Y, Cho H, Hwang J Drug Des Devel Ther. 2022; 16:3263-3274.

PMID: 36177347 PMC: 9514787. DOI: 10.2147/DDDT.S376821.

Risk factors associated with hypophosphatemia in chronic Hepatitis B patients treated with tenofovir disoproxil fumarate.

Lee D, Yun B, Seo K, Han B, Lee S, Park E Medicine (Baltimore). 2019; 98(50):e18351.

PMID: 31852136 PMC: 6922420. DOI: 10.1097/MD.0000000000018351.

Association of higher plasma vitamin D binding protein and lower free calcitriol levels with tenofovir disoproxil fumarate use and plasma and intracellular tenofovir pharmacokinetics: cause of a functional vitamin D deficiency?.

Havens P, Kiser J, Stephensen C, Hazra R, Flynn P, Wilson C Antimicrob Agents Chemother. 2013; 57(11):5619-28.

PMID: 24002093 PMC: 3811269. DOI: 10.1128/AAC.01096-13.

Update on tenofovir toxicity in the kidney.

Hall A Pediatr Nephrol. 2012; 28(7):1011-23.

PMID: 22878694 DOI: 10.1007/s00467-012-2269-7.